Fused pyrolines that act as ubiquitin-specific protease 30 (USP30) inhibitors

MA53816AUndetermined Publication Date: 2022-04-06FORMA THERAPEUTICS INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA53816
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2018-10-05
Filing Date: 2019-10-04
Publication Date: 2022-04-06

Application Information

Patent Timeline

05 Oct 2018

Priority

04 Oct 2019

Application

MA53816

06 Apr 2022

Publication

MA53816A

IPC: A61K31/4155; A61K31/4439; A61P25/00; A61P25/16; C07D401/14; C07D403/12; C07D417/12; C07D417/14; C07D487/08

CPC: C07D487/08; C07D403/12; C07D401/14; A61P25/16; A61P25/00; C07D491/107; C07D487/18; C07D471/08

Inventors: BUCKMELTER Alex J.; CARAVELLA Justin Andrew

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.